Results 21 to 30 of about 265,325 (306)

Using and interpreting cost-effectiveness acceptability curves: an example using data from a trial of management strategies for atrial fibrillation [PDF]

, 2006
Background: The cost-effectiveness acceptability curve (CEAC) is a method for summarizing the uncertainty in estimates of cost-effectiveness. The CEAC, derived from the joint distribution of costs and effects, illustrates the (Bayesian) probability ...
Deborah A Marshall, Levy, Adrian R, Nichol, G., Fenwick Elisabeth, Adrian R Levy, Fenwick, E., Graham Nichol, Elisabeth Fenwick, Marshall, Deborah A, Nichol, Graham, Marshall, D.A., Levy, A.R., Levy Adrian R, Marshall Deborah A, Nichol Graham, Fenwick, Elisabeth   +15 more
core   +1 more source

LONG-TERM ADHERENCE TO FLECAINIDE AS A RHYTHM CONTROL THERAPY IN RECURRENT ATRIAL FIBRILLATION - A RETROSPECTIVE COHORT STUDY

, 2022
Background: The choice of rhythm control drugs for recurrent atrial fibrillation (AF) remains empirical and is based on the safety profile rather than predicted efficacy.
Carlson, Jonas,, Johansson, Samuel, Madsen Hardig, Bjarne,, Wagner, Henrik,, Lund University., Platonov, P.G.,, Siotis, Alexander,   +6 more
core   +1 more source

Personified approach to diagnostics and treatment of atrial fibrillation. Diagnostic stage (part 1)

Лечащий Врач, 2021
The article presents a review of mechanisms, diagnostics and possible predictors of atrial fibrillation recurrence, as well as the analysis of available scientifically proved therapeutic approaches to the treatment of patients with this arrhythmia.
E. A. Praskurnichii, O. I. Morozova
doaj  

Effect of clinic-based single-lead electrocardiogram rhythm assessment on oral anticoagulation prescriptions in patients with previously diagnosed atrial fibrillation

, 2023
Background: Despite benefits of oral anticoagulation (OAC), many individuals with diagnosed atrial fibrillation (AF) do not receive OAC. Objective: The purpose of this study was to assess whether cardiac rhythm assessment for AF impacted use of OAC in ...
Ashburner, Jeffrey M, Khurshid, Shaan, Singer, Daniel E, Atlas, Steven J, McManus, David D, Borowsky, Leila H, Chang, Yuchiao, Lubitz, Steven A, Ellinor, Patrick T   +8 more
core   +1 more source

Chronic Kidney Disease with Mild and Mild to Moderate Reduction in Renal Function and Long-Term Recurrences of Atrial Fibrillation after Pulmonary Vein Cryoballoon Ablation

Journal of Cardiovascular Development and Disease, 2022
The aim of this research was to evaluate if patients with chronic kidney disease (CKD) and mild or mild to moderate depression of renal function have an increased risk of atrial fibrillation (AF) recurrences after cryoballoon (CB) ablation.
Giuseppe Boriani, Saverio Iacopino, Giuseppe Arena, Paolo Pieragnoli, Roberto Verlato, Massimiliano Manfrin, Giulio Molon, Giovanni Rovaris, Antonio Curnis, Giovanni Battista Perego, Antonio Dello Russo, Maurizio Landolina, Marco Vitolo, Claudio Tondo, on behalf of the 1STOP ClinicalService Investigators   +14 more
doaj   +1 more source

Rhythm control strategy in the transcatheter ablation era [PDF]

Ķazaķstannyṇ Klinikalyķ Medicinasy, 2021
The latest ESC guidelines on atrial fibrillation limit rhythm control to symptomatic cases, continuing on the same line that the Affirm and Race trials traced twenty years ago.
Riccardo Maddalena
doaj   +1 more source

Pulsed field ablation: focused on atrial fibrillation ablation [PDF]

The Korean Journal of Internal Medicine
Atrial fibrillation (AF) is the most common sustained tachyarrhythmia and its increasing prevalence has resulted in a growing healthcare burden. Catheter ablation is indicated for patients with AF who are either refractory or intolerant to antiarrhythmic
Hong-Ju Kim, Chan-Hee Lee
doaj   +1 more source

Atrial fibrillation in the elderly population: Challenges and management considerations

Journal of Arrhythmia, 2021
Importance Atrial fibrillation is the most clinically significant arrhythmia in humans when viewed both from a global and also a national perspective. In the United States, approximately 2.7‐6.1 million people are estimated to have atrial fibrillation ...
Mohammed Salih, Osama Abdel‐Hafez, Ramzi Ibrahim, Rajiv Nair   +3 more
doaj   +1 more source

RHYTHM-AF: design of an international registry on cardioversion of atrial fibrillation and characteristics of participating centers [PDF]

, 2012
BACKGROUND Atrial fibrillation is a serious public health problem posing a considerable burden to not only patients, but the healthcare environment due to high rates of morbidity, mortality, and medical resource utilization. There are limited data on the
Rosenqvist Mårten, Alexandra A Bernhardt, Anselm K Gitt, Phatak Hemant M, Chazelle, Francois, Bash, Lori D., Unniachan Sreevalsa, Sanders, P., Scanavacca Mauricio, Crijns, H., Unniachan, Sreevalsa, Harry JGM Crijns, Crijns, Harry J. G. M., Le Heuzey Jean-Yves, Gregory YH Lip, Lewalter Thorsten, Maggioni, A., Bash, L., Ponikowski, P., Bash Lori D, Maggioni Aldo P, Aldo P Maggioni, Hemant M Phatak, Rosenqvist, M., Lewalter, T., Lewalter, Thorsten, Sanders, Prashanthan, Ponikowski, Piotr, Alfonso Martín, Gitt, Anselm K., Thorsten Lewalter, Maggioni, Aldo P., Scanavacca, M., Ponikowski Piotr, Phatak, Hemant M., Unniachan, S., Chazelle, F., Le Heuzey, J., Prashanthan Sanders, Gitt, A., Scanavacca, Mauricio, Lori D Bash, Crijns Harry JGM, Martín Alfonso, Mårten Rosenqvist, Rosenqvist, Marten, François Chazelle, Chazelle François, Lip, G., Gitt Anselm K, Phatak, H., Piotr Ponikowski, Bernhardt, A., Lip Gregory YH, Jean-Yves Le Heuzey, Martin, A., Sanders Prashanthan, Martin, Alfonso, Mauricio Scanavacca, Le Heuzey, Jean-Yves, Sreevalsa Unniachan, Bernhardt, Alexandra A., Lip, Gregory Y. H., Bernhardt Alexandra A   +63 more
core   +1 more source

Chapter 2: Rate Versus Rhythm Control

, 2023
Atrial fibrillation (AF) is a potentially serious health risk, both because of its symptoms and because of its association with an increased risk for heart failure, hospitalization, thromboembolism, and death. Chapter 2 discusses selection of appropriate
Deering, Thomas F, Tamirisa, Kamala P, Kamala P. Tamirisa, Solomon, Allen J, Reiffel, James A, Thomas F. Deering, James A. Reiffel, Allen J. Solomon   +7 more
core   +1 more source